Lv31
216 积分 2024-01-31 加入
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2天前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
29天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
30天前
已完结
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis
30天前
已完结
Predictors of achieving minimal manifestations or better status in ocular myasthenia gravis with immunotherapy
1个月前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
1个月前
已完结
The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis
1个月前
已完结
CAR T-Cell Therapy in Autoimmune Disease
7个月前
已完结
Small molecule improves muscle function in myasthenia gravis
7个月前
已完结
皖公网安备34019202002308
